Change search
ReferencesLink to record
Permanent link

Direct link
Generation and evaluation of bispecific affibody molecules for simultaneous targeting of EGFR and HER2
KTH, School of Biotechnology (BIO), Molecular Biotechnology.
Show others and affiliations
2012 (English)In: Bioconjugate chemistry, ISSN 1043-1802, E-ISSN 1520-4812, Vol. 23, no 9, 1802-1811 p.Article in journal (Refereed) Published
Abstract [en]

Coexpression of several ErbB receptors has been found in many cancers and has been linked with increased aggressiveness of tumors and a worse patient prognosis. This makes the simultaneous targeting of two surface receptors by using bispecific constructs an increasingly appreciated strategy. Here, we have generated six such bispecific targeting proteins, each comprising two monomeric affibody molecules with specific binding to either of the two human epidermal growth factor receptors, EGFR and HER2, respectively. The bispecific constructs were designed with (i) alternative positioning (N- or C-terminal) of the different affibody molecules, (ii) two alternative peptide linkers (Gly 4Ser) 3 or (Ser 4Gly) 3, and (iii) affibody molecules with different affinity (nanomolar or picomolar) for HER2. Using both Biacore technology and cell binding assays, it was demonstrated that all six constructs could bind simultaneously to both their target proteins. N-terminal positioning of the inherent monomeric affibody molecules was favorable to promote the binding to the respective target. Interestingly, bispecific constructs containing the novel (Ser 4Gly) 3 linker displayed a higher affinity in cell binding, as compared to constructs containing the more conventional linker, (Gly 4Ser) 3. It could further be concluded that bispecific constructs (but not the monomeric affibody molecules) induced dimer formation and phosphorylation of EGFR in SKBR3 cells, which express fairly high levels of both receptors. It was also investigated whether the bispecific binding would influence cell growth or sensitize cells for ionizing radiation, but no such effects were observed.

Place, publisher, year, edition, pages
2012. Vol. 23, no 9, 1802-1811 p.
Keyword [en]
bispecific affibody molecule, epidermal growth factor receptor, epidermal growth factor receptor 2, peptides and proteins, unclassified drug
National Category
Biochemistry and Molecular Biology
URN: urn:nbn:se:kth:diva-103554DOI: 10.1021/bc3000645ISI: 000308833600011ScopusID: 2-s2.0-84866357369OAI: diva2:560453
VinnovaSwedish Research Council

QC 20121015

Available from: 2012-10-15 Created: 2012-10-15 Last updated: 2012-10-31Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textScopus

Search in DiVA

By author/editor
Wållberg, HelenaStåhl, Stefan
By organisation
Molecular Biotechnology
In the same journal
Bioconjugate chemistry
Biochemistry and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 42 hits
ReferencesLink to record
Permanent link

Direct link